Pro-Moieties of Antimicrobial Peptide Prodrugs
AbstractAntimicrobial peptides (AMPs) are a promising class of antimicrobial agents that have been garnering increasing attention as resistance renders many conventional antibiotics ineffective. Extensive research has resulted in a large library of highly-active AMPs. However, several issues serve as an impediment to their clinical development, not least the issue of host toxicity. An approach that may allow otherwise cytotoxic AMPs to be used is to deliver them as a prodrug, targeting antimicrobial activity and limiting toxic effects on the host. The varied library of AMPs is complemented by a selection of different possible pro-moieties, each with their own characteristics. This review deals with the different pro-moieties that have been used with AMPs and discusses the merits of each. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Forde, E.; Devocelle, M. Pro-Moieties of Antimicrobial Peptide Prodrugs. Molecules 2015, 20, 1210-1227.
Forde E, Devocelle M. Pro-Moieties of Antimicrobial Peptide Prodrugs. Molecules. 2015; 20(1):1210-1227.Chicago/Turabian Style
Forde, Eanna; Devocelle, Marc. 2015. "Pro-Moieties of Antimicrobial Peptide Prodrugs." Molecules 20, no. 1: 1210-1227.